Managing Partner: Matthew J Becker
Number of partners: 33
Number of lawyers: 95
Axinn combines the skills, experience and dedication of the world’s largest firms with the focus, responsiveness, efficiency and attention to client needs of the best boutiques. The firm was established in the late 1990s by lawyers from premier Wall Street firms with a common vision: provide the highest level of service and strategic acumen in antitrust, intellectual property and high-stakes litigation. Axinn’s lawyers have served as lead or co-lead counsel on nearly half a trillion dollars in transactions and, in the last 10 years alone, have handled more than 250 litigations.
Main Areas of Practice:
Axinn has more than 50 full time antitrust lawyers working on M&A, litigation, criminal and conduct investigations. Axinn has been global lead on mergers worth close to half a trillion dollars, including: Dell’s $67 billion acquisition of EMC; Thermo Fisher’s $13.2 billion acquisition of life technologies; Ball Corporation’s $6 billion acquisition of Rexam; Johnson Controls’ $2 billion sale of Scott Safety to 3M; and McKesson’s $3.4 billion joint venture with Change Healthcare. Axinn has extensive experience in major trials and class actions, including In Re Blue Cross antitrust litigation (for IBC), Poultry Growers antitrust litigation (for Tyson Foods), In Re Surescripts litigation (for RelayHealth, a subsidiary of McKesson), SawStop (for Stanley Black & Decker), biosimilar antitrust litigation (for Momenta), German and Asian Auto Parts litigation, as well as monopolisation and conspiracy cases for Thermo Fisher, Danfoss, Hexcel, University of Pittsburgh Medical Center and Affinia. The firm has litigated six merger cases brought by government agencies (winning five) and has a strong presence and track record in ongoing DOJ criminal antitrust matters and related litigation, including in auto parts and air cargo. The antitrust group has extensive experience on matters involving antitrust and IP issues, including Google’s settlement with the Federal Trade Commission on standard essential patents. Axinn has deep contacts with the staff and front offices of FTC and DOJ in both Republican and Democratic administrations and employs lawyers with nearly 100 years of government antitrust experience.
Contacts: John D Harkrider, Michael L Keeley (Co-Chairs)
Emails: [email protected], [email protected]
Axinn has numerous seasoned IP trial lawyers and has become a go-to firm for IP matters of strategic importance. The IP Group has handled some of the largest and most challenging matters, including multi-billion dollar patent cases and those involving sophisticated IP issues that do not fit neatly into a company’s routine litigation profile. Members of the Group have served as lead or co-lead counsel on more than 250 litigations in the last 10 years alone, including in some of the most significant recent patent cases for the world’s leading pharmaceutical, technology, biotech, medical device, diagnostics, and consumer products companies, including Johnson & Johnson, Samsung, Unilever, Alvogen, and Par Pharmaceuticals. On numerous occasions, the firm has been asked to take over cases during or after discovery and serve as lead counsel at trial, including the defense of a multi-billion dollar jury trial. Utilizing their advocacy skills within the last few years, Axinn attorneys have obtained, for example, a favorable Federal Circuit decision on a novel double patenting legal issue that led to a settlement allowing the firm’s client to market an important influenza treatment; a multi-million dollar jury verdict in a medical device patent case involving spinal implants; and the first-ever decision by a district court ordering FDA to approve a generic version of a drug. In addition to serving as lead trial counsel, the firm is often engaged by its clients to handle appeals to the Federal Circuit, Inter Partes Review proceedings, and complex licensing and due diligence matters. Attorneys also offer an exceptional depth of technical experience, including numerous attorneys with advanced technical degrees and extensive hands-on industry training. In addition, the firm has a leading FDA practice.
Contact: Chad A Landmon (Chair)
Email: [email protected]
Axinn serves clients for whom high-stakes litigation is a vital or unavoidable aspect of business. In recent years, Axinn has defeated billions of dollars in asserted liability for defendants and obtained hundreds of millions of dollars for plaintiffs. Axinn lawyers regularly try cases across the US and in arbitral forums, and are often brought in to handle cases that are close to trial. Axinn has unusually broad experience representing both plaintiffs and defendants. The firm has devised creative solutions for clients that have earned them hundreds of millions of dollars as plaintiffs. Axinn lawyers have also successfully defended the firm’s clients against class actions and business disputes involving everything from insurance coverage, auction rate securities, cybersecurity, data breaches and health care financing, to cell phones, infant formula, auto parts and cable television. Axinn has a particular focus on the needs of the financial services industry, and represents many of the world’s leading insurers, hedge funds, private equity firms, and mutual funds. Axinn is also frequently involved in international matters and represents clients in forums from the Cayman Islands and Jersey to ICC arbitrations.
Contact: Thomas G. Rohback (Chair)
Email: [email protected]